Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 250

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 250
---
emplar reporting unit was 13.0% for 2024 and 12.5% for 2023, and the terminal growth rate used in the discounted cash flow model was 3% for both 2024 and 2023. See Note 16 for information regarding goodwill by reportable segment.Intangible assets consist of the following as of December 31, 2024: Weighted Average Useful Life (Years)Gross Carrying AmountAccumulated AmortizationNetPatents, developed technologies and know-how10.7$15,912 $(11,457)$4,455 Intangible assets consist of the following as of December 31, 2023: Gross Carrying AmountAccumulated AmortizationNetPatents, developed technologies and know-how$82,501 $(41,800)$40,701 During 2024, in connection with the suspension of ActoBio's operations, the Company determined the fair value of ActoBio's certain developed technologies was less than their carrying amount. As a result, the Company recorded an impairment charge of $32,317, which is included in impairment of other noncurrent assets in the accompanying consolidated statements of operations for the year ended December 31, 2024.Amortization expense was $3,059, $4,848, and $4,798 for the years ended December 31, 2024, 2023, and 2022, respectively. Estimated aggregate amortization expense for definite lived intangible assets is expected to be as follows:2025$1,273 20261,273 20271,273 2028636 Total$4,455 

F-32

10. Debt

Lines of CreditExemplar has a $5,000 revolving line of credit with American State Bank that matures on November 1, 2025. As of December 31, 2024, the line of credit bore interest at 8.00% per annum. As of December 31, 2024 and December 31, 2023, there was no outstanding balance.Convertible NotesIn July 2018, Precigen completed a registered underwritten public offering of $200,000 aggregate principal amount of Convertible Notes and issued the Convertible Notes under an indenture (the "Base Indenture") between Precigen and The Bank of New York Mellon Trust Company, N.A., as trustee, as supplemented by the First Supplemental Indent